Overview

Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
0
Participant gender:
All
Summary
To study the efficacy of an antibacterial/anticoagulant solution instilled into the hemodialysis (HD) catheters after each treatment ("antibiotic lock solution - ALS") to prevent catheter related bacteremia (CRB) and to salvage catheters with established CRB.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Henry Ford Health System
Treatments:
Gentamicins
Minocycline
Criteria
Inclusion Criteria:

- ESRD patients with tunnelled catheters

Exclusion Criteria:

- patients on IV abx for infections, patients who have AV graft, AV fistulas